Determination of Regulatory Review Period for Purposes of Patent Extension; TYZEKA; Correction

---
identifier: "/us/fr/E8-12300"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Determination of Regulatory Review Period for Purposes of Patent Extension; TYZEKA; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "E8-12300"
section_name: "Determination of Regulatory Review Period for Purposes of Patent Extension; TYZEKA; Correction"
positive_law: false
currency: "2008-06-03"
last_updated: "2008-06-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-12300"
document_type: "notice"
publication_date: "2008-06-03"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "73 FR 31697"
fr_volume: 73
docket_ids:
  - "Docket No. FDA-2007-E-0335"
fr_action: "Notice; correction."
---


#  Determination of Regulatory Review Period for Purposes of Patent Extension; TYZEKA; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of May 15, 2008 (73 FR 28119), announcing FDA's determination of the regulatory review period for TYZEKA. The document published with an incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy, Planning and Preparedness (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7630.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. E8-10857, published on May 15, 2008 (73 FR 28119), the following correction is made:

On page 28119, in the third column, in the Docket No. heading, “Docket No. FDA-2007-E-0035” is corrected to read “Docket No. FDA-2007-E-0335”.

Dated: May 27, 2008.

Jeffrey Shuren,

Associate Commissioner for Policy and Planning.